Daniel Shlomo Mishkin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy, Gastrointestinal | 10 | 2023 | 887 | 0.720 |
Why?
|
| Endoscopes, Gastrointestinal | 7 | 2009 | 45 | 0.700 |
Why?
|
| Breath Tests | 5 | 2004 | 300 | 0.670 |
Why?
|
| Malabsorption Syndromes | 3 | 2004 | 135 | 0.570 |
Why?
|
| Gastrointestinal Agents | 3 | 2021 | 510 | 0.550 |
Why?
|
| Pregnancy Complications | 6 | 2020 | 2972 | 0.400 |
Why?
|
| Sorbitol | 2 | 2004 | 61 | 0.380 |
Why?
|
| Cathartics | 2 | 2023 | 129 | 0.370 |
Why?
|
| Sulfates | 2 | 2023 | 379 | 0.370 |
Why?
|
| Crohn Disease | 4 | 2023 | 2293 | 0.350 |
Why?
|
| Esophageal and Gastric Varices | 3 | 2008 | 215 | 0.330 |
Why?
|
| Metoclopramide | 1 | 2009 | 51 | 0.330 |
Why?
|
| Peptic Ulcer | 2 | 2020 | 222 | 0.300 |
Why?
|
| Intestine, Small | 3 | 2007 | 1218 | 0.290 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2008 | 56 | 0.290 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2007 | 520 | 0.270 |
Why?
|
| Hydrogen | 2 | 2004 | 171 | 0.260 |
Why?
|
| Miniaturization | 1 | 2006 | 153 | 0.250 |
Why?
|
| Pregnancy Outcome | 6 | 2020 | 2961 | 0.250 |
Why?
|
| Methane | 1 | 2004 | 44 | 0.230 |
Why?
|
| Pouchitis | 1 | 2024 | 64 | 0.230 |
Why?
|
| Carbohydrate Metabolism | 1 | 2004 | 262 | 0.210 |
Why?
|
| Intestinal Perforation | 2 | 2018 | 253 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 536 | 0.210 |
Why?
|
| Colonoscopy | 4 | 2023 | 1412 | 0.200 |
Why?
|
| Colonic Diseases, Functional | 1 | 2001 | 39 | 0.190 |
Why?
|
| Magnesium Sulfate | 1 | 2021 | 73 | 0.180 |
Why?
|
| Potassium Chloride | 1 | 2021 | 229 | 0.180 |
Why?
|
| Ribavirin | 1 | 2001 | 395 | 0.160 |
Why?
|
| Polyethylene Glycols | 2 | 2023 | 1195 | 0.160 |
Why?
|
| Endosonography | 3 | 2007 | 622 | 0.160 |
Why?
|
| Intestinal Obstruction | 1 | 2002 | 435 | 0.150 |
Why?
|
| Lactose Intolerance | 1 | 1997 | 28 | 0.150 |
Why?
|
| Cholecystitis, Acute | 1 | 2018 | 81 | 0.150 |
Why?
|
| Abdominal Abscess | 1 | 2018 | 153 | 0.140 |
Why?
|
| Interferon-alpha | 1 | 2001 | 910 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2009 | 1126 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1997 | 120 | 0.140 |
Why?
|
| Dyspepsia | 1 | 1997 | 116 | 0.140 |
Why?
|
| Laparotomy | 1 | 2018 | 459 | 0.130 |
Why?
|
| Piperidines | 1 | 2024 | 1659 | 0.130 |
Why?
|
| Equipment Design | 10 | 2009 | 3529 | 0.130 |
Why?
|
| Fructose | 1 | 1997 | 284 | 0.130 |
Why?
|
| Celiac Disease | 2 | 2019 | 820 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 4357 | 0.120 |
Why?
|
| Pancreatic Diseases | 2 | 2007 | 353 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 3 | 2007 | 1207 | 0.110 |
Why?
|
| Fetus | 1 | 2001 | 1883 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2001 | 1397 | 0.110 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 1929 | 0.100 |
Why?
|
| Contrast Media | 1 | 2005 | 5336 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2024 | 3048 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2018 | 774 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2021 | 2258 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 708 | 0.090 |
Why?
|
| Ligation | 2 | 2008 | 447 | 0.090 |
Why?
|
| Glucose | 1 | 2002 | 4352 | 0.090 |
Why?
|
| Colon | 1 | 1997 | 1805 | 0.080 |
Why?
|
| Technology Assessment, Biomedical | 3 | 2007 | 309 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9261 | 0.080 |
Why?
|
| Telemedicine | 1 | 2006 | 3107 | 0.080 |
Why?
|
| Remission Induction | 2 | 2021 | 2407 | 0.080 |
Why?
|
| Sclerosing Solutions | 1 | 2007 | 79 | 0.070 |
Why?
|
| Lithotripsy, Laser | 1 | 2007 | 45 | 0.070 |
Why?
|
| Disinfection | 1 | 2009 | 207 | 0.070 |
Why?
|
| Vena Cava, Superior | 1 | 2008 | 197 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2018 | 2056 | 0.070 |
Why?
|
| Humans | 41 | 2024 | 768393 | 0.070 |
Why?
|
| Dihematoporphyrin Ether | 1 | 2006 | 33 | 0.070 |
Why?
|
| Pregnancy | 7 | 2020 | 30200 | 0.070 |
Why?
|
| Equipment Safety | 4 | 2008 | 250 | 0.070 |
Why?
|
| Lithotripsy | 1 | 2007 | 141 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 552 | 0.070 |
Why?
|
| Sclerotherapy | 1 | 2007 | 183 | 0.060 |
Why?
|
| Digestive System Neoplasms | 1 | 2006 | 83 | 0.060 |
Why?
|
| Disposable Equipment | 1 | 2005 | 46 | 0.060 |
Why?
|
| Warfarin | 1 | 2014 | 1493 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1304 | 0.060 |
Why?
|
| Cholelithiasis | 1 | 2007 | 408 | 0.060 |
Why?
|
| Biliary Tract Diseases | 1 | 2006 | 159 | 0.060 |
Why?
|
| Endoscopy, Digestive System | 1 | 2008 | 357 | 0.060 |
Why?
|
| Pancreatitis | 2 | 2009 | 1087 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15881 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 564 | 0.060 |
Why?
|
| Digestive System Diseases | 1 | 2006 | 152 | 0.060 |
Why?
|
| Carbon Dioxide | 1 | 2009 | 1149 | 0.060 |
Why?
|
| Stents | 2 | 2006 | 3201 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2400 | 0.060 |
Why?
|
| Sulfur Compounds | 1 | 2023 | 32 | 0.060 |
Why?
|
| Salts | 1 | 2023 | 61 | 0.050 |
Why?
|
| Lactulose | 1 | 2002 | 32 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2007 | 708 | 0.050 |
Why?
|
| Colonic Polyps | 1 | 2007 | 557 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2014 | 3461 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2006 | 631 | 0.050 |
Why?
|
| Female | 16 | 2024 | 397089 | 0.050 |
Why?
|
| Heart Atria | 1 | 2008 | 1360 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 1434 | 0.050 |
Why?
|
| Tablets | 1 | 2021 | 149 | 0.040 |
Why?
|
| Fertilization | 1 | 2001 | 198 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 641 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2023 | 659 | 0.040 |
Why?
|
| Photochemotherapy | 1 | 2006 | 830 | 0.040 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2007 | 959 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 1525 | 0.040 |
Why?
|
| Adult | 9 | 2024 | 223640 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4843 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1802 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 682 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20224 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 655 | 0.040 |
Why?
|
| Fermentation | 1 | 1997 | 142 | 0.040 |
Why?
|
| Placebos | 1 | 2021 | 1668 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2021 | 1585 | 0.030 |
Why?
|
| Reference Values | 1 | 2004 | 4941 | 0.030 |
Why?
|
| Gastrointestinal Transit | 1 | 1997 | 101 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 1997 | 400 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2020 | 41795 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2024 | 4039 | 0.030 |
Why?
|
| Reading | 1 | 2020 | 543 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 1676 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2005 | 5538 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2016 | 286 | 0.030 |
Why?
|
| Current Procedural Terminology | 2 | 2006 | 101 | 0.030 |
Why?
|
| Patient Care Management | 1 | 2018 | 304 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2024 | 9379 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2491 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2544 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2021 | 2079 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 15939 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2020 | 26411 | 0.030 |
Why?
|
| Middle Aged | 6 | 2024 | 223491 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2139 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 2001 | 1031 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 14737 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2024 | 65379 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10776 | 0.020 |
Why?
|
| Male | 8 | 2024 | 364902 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 6510 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2020 | 81801 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2014 | 24318 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2024 | 8731 | 0.020 |
Why?
|
| Costs and Cost Analysis | 2 | 2007 | 1669 | 0.020 |
Why?
|
| Bacteria | 1 | 2002 | 2221 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2014 | 676 | 0.020 |
Why?
|
| Radiography | 1 | 2002 | 6993 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1857 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 2006 | 2126 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 1915 | 0.020 |
Why?
|
| Mass Screening | 1 | 2004 | 5451 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3486 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 5708 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2014 | 1161 | 0.020 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2007 | 44 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12456 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22296 | 0.020 |
Why?
|
| Duodenal Diseases | 1 | 2006 | 101 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6519 | 0.020 |
Why?
|
| Risk Factors | 3 | 2019 | 74962 | 0.020 |
Why?
|
| Esophageal Diseases | 1 | 2006 | 168 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2007 | 330 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 2006 | 134 | 0.010 |
Why?
|
| Laser Coagulation | 1 | 2007 | 333 | 0.010 |
Why?
|
| Esophageal Stenosis | 1 | 2006 | 197 | 0.010 |
Why?
|
| Injections | 1 | 2007 | 840 | 0.010 |
Why?
|
| Needles | 1 | 2007 | 461 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 60049 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15872 | 0.010 |
Why?
|
| Safety | 1 | 2007 | 1159 | 0.010 |
Why?
|
| Research Design | 1 | 2018 | 6210 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7463 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171562 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1627 | 0.010 |
Why?
|
| Barrett Esophagus | 1 | 2006 | 494 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13323 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54920 | 0.010 |
Why?
|
| United States | 2 | 2020 | 73150 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 36510 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2007 | 3048 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2008 | 3960 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 6808 | 0.010 |
Why?
|
| Child | 1 | 2023 | 80891 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 30022 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 89184 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10377 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 11254 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 59686 | 0.000 |
Why?
|